Home/Climb Bio/Douglas E. Williams, PhD

DE

Douglas E. Williams, PhD

Chairman of the Board

Therapeutic Areas

Immune-Mediated Diseases Autoimmune Diseases

Climb Bio Pipeline

Drug	Indication	Phase
Budoprutug	Immune-Mediated Diseases (Undisclosed)	Clinical
CLYM116	Immune-Mediated Diseases (Undisclosed)	Clinical

Leadership Team at Climb Bio

Aoife Brennan, MB, ChB

President and Chief Executive Officer

Edgar Charles, MD

Chief Medical Officer

Susan Altschuller, PhD, MBA

Chief Financial Officer

View full Climb Bio profile